---
$id: https://graph.org.ai/products/commodity/51263011
$type: Product
source: UNSPSC
code: "51263011"
title: "Terazosin hydrochloride anhydrous"
class: "51263000"
classTitle: "Adrenergic blocking agent piperazines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Terazosin hydrochloride anhydrous

**UNSPSC Code**: 51263011
**Class**: [Adrenergic blocking agent piperazines](Adrenergic blocking agent piperazines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H25N5O4.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8QOP8Z9955. European Medicines Agency schedules terazosin hcl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04722MIG. Most nations, for tariff and trade purposes, schedule terazosin hydrochloride anhydrous under HS 29349990 and SITC 51579. As of Q4 2014, TERAZOSIN HYDROCHLORIDE ANHYDROUS remains US FDA's Preferred Term for this commodity. Terazosin hydrochloride anhydrous bears US NLM identifiers UMLS ID C2241271 and NCI Concept Code C75056. SMILES: COC1CC2C(CC1OC)NC(NC2N)N3CCN(CC3)C(=O)C4CCCO4.CL.

